Terminology Service for NFDI4Health
All terms in BAO
| Label | Id | Description |
|---|---|---|
| emulsifier | CHEBI_63046 | |
| lumiphore | CHEBI_35197 | |
| photochemical role | CHEBI_52215 | |
| antigen | CHEBI_59132 | |
| cleft lip | DOID_9296 | |
| orofacial cleft | DOID_0050567 | |
| priapism | DOID_9286 | [A peripheral vascular disease characterized by blood trapped in the penis that is unable to drain.] |
| peripheral vascular disease | DOID_341 | [A vascular disease that is characterized by obstruction of larger arteries not within the coronary, aortic arch vasculature, or brain.] |
| EC 1.14.14.14 (aromatase) inhibitor | CHEBI_50790 | |
| EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor | CHEBI_76838 | |
| estrogen receptor antagonist | CHEBI_50792 | |
| CB2 receptor antagonist | CHEBI_73417 | |
| cannabinoid receptor antagonist | CHEBI_73413 | |
| CB1 receptor antagonist | CHEBI_73416 | |
| lip disease | DOID_9297 | |
| alkaptonuria | DOID_9270 | [An amino acid metabolic disorder that involves phenylalanine and tyrosine metabolism with the accumulation of homogentisic acid, a toxic tyrosine byproduct.] |
| amino acid metabolic disorder | DOID_9252 | [An inherited metabolic disorder that is characterized by impaired synthesis and degradation of amino acids.] |
| hyperlysinemia | DOID_9274 | [An amino acid metabolic disorder that involves an abnormal increase of lysine in the blood.] |
| EC 1.15.1.1 (superoxide dismutase) inhibitor | CHEBI_134084 | |
| EC 1.15.* (oxidoreductase acting on superoxide as acceptor) inhibitor | CHEBI_76742 |